Clinical Trials Directory

Trials / Completed

CompletedNCT05510999

The Efficacy of Graminex® Flower Pollen Extracts in Healthy Women With Urinary Incontinence

A Randomized, Double-blind, Placebo-controlled, Study to Investigate the Efficacy of Graminex® Flower Pollen Extracts in Healthy Women With Urinary Incontinence.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
190 (actual)
Sponsor
Graminex LLC · Academic / Other
Sex
Female
Age
40 Years – 75 Years
Healthy volunteers
Accepted

Summary

The primary objective of this study is to investigate the effect of Graminex® Flower Pollen Extracts in healthy women with urinary incontinence. The change in severity of urinary incontinence between baseline and 24 weeks will be assessed by an International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF), and compared between the investigational product and placebo groups. Additionally, the safety and tolerability of Graminex® Flower Pollen Extracts, as compared to placebo, will be measured by the occurrence of and/or changes in treatment-emergent adverse events (AEs).

Conditions

Interventions

TypeNameDescription
OTHERPlaceboOne capsule of placebo will be taken twice daily for 24 weeks.
DIETARY_SUPPLEMENTWater soluble pollen extract fractionEach capsule contains 180 mg of water soluble pollen extract fraction. One capsule will be taken twice daily (360 mg/day) for 24 weeks.
DIETARY_SUPPLEMENTLipid soluble pollen extract fraction + water soluble pollen extract fractionEach capsule contains a combination of 9 mg of lipid soluble pollen extract fraction and 180 mg of water soluble pollen extract fraction. One capsule will be taken twice daily (18 mg/day and 360 mg/day, respectively) for 24 weeks.
DIETARY_SUPPLEMENTLipid soluble pollen extract fractionEach capsule contains 9 mg of lipid soluble pollen extract fraction. One capsule of will be taken twice daily (18 mg/day) for 24 weeks.
DIETARY_SUPPLEMENTWater soluble pollen extract fraction + cranberry powderEach capsule contains a combination of 42 mg of water soluble pollen extract and 125 mg of cranberry powder. One capsule will be taken twice daily (84 mg/day and 250 mg/day, respectively) for 24 weeks.

Timeline

Start date
2019-06-17
Primary completion
2021-10-26
Completion
2021-10-26
First posted
2022-08-22
Last updated
2022-08-22

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05510999. Inclusion in this directory is not an endorsement.